These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12059854)

  • 21. Unexpected and prolonged akinesia: a case report.
    Fink EB
    J Clin Psychiatry; 1978 Nov; 39(11):817-8. PubMed ID: 31353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Withdrawal symptoms of neuroleptics?].
    Mager T
    Med Monatsschr Pharm; 1994 Aug; 17(8):252. PubMed ID: 7935155
    [No Abstract]   [Full Text] [Related]  

  • 23. Extrapyramidal symptoms and oestrogen.
    Thompson KN; Kulkarni J; Sergejew AA
    Acta Psychiatr Scand; 2000 Feb; 101(2):130-4. PubMed ID: 10706013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clozapine withdrawal rebound psychosis.
    Borison RL; Diamond BI; Sinha D; Gupta RP; Ajiboye PA
    Psychopharmacol Bull; 1988; 24(2):260-3. PubMed ID: 3212159
    [No Abstract]   [Full Text] [Related]  

  • 25. [Complications of drug withdrawal from antiparkinson agents and neuroleptics].
    Mizon JP; Rosa A
    Therapie; 1984; 39(4):421-5. PubMed ID: 6148792
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of maintenance use of anticholinergic agents.
    Double DB; Warren GC; Evans M; Rowlands RP
    Acta Psychiatr Scand; 1993 Nov; 88(5):381-4. PubMed ID: 7905226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Life-threatening neuroleptic withdrawal emergent syndrome resembling status dystonicus.
    Pugin D; Bally J; Horvath J; Pollak P; Gasche Y; Burkhard PR
    Parkinsonism Relat Disord; 2017 Feb; 35():96-97. PubMed ID: 27914829
    [No Abstract]   [Full Text] [Related]  

  • 28. Psychotic disorders and gonadal function: evidence supporting the oestrogen hypothesis.
    Huber TJ; Borsutzky M; Schneider U; Emrich HM
    Acta Psychiatr Scand; 2004 Apr; 109(4):269-74. PubMed ID: 15008800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroleptic malignant syndrome precipitated by haloperidol following clozapine discontinuation.
    Mendhekar DN; Jiloha RC
    Aust N Z J Psychiatry; 2005 Oct; 39(10):947-8. PubMed ID: 16168023
    [No Abstract]   [Full Text] [Related]  

  • 30. Perphenazine-Associated Nausea: A Case of Protracted Withdrawal.
    Singh N; Sood N; Jolly T
    J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):606-608. PubMed ID: 34369907
    [No Abstract]   [Full Text] [Related]  

  • 31. [Anticholinergics during neuroleptic treatment. Value and withdrawal].
    Betermiez P; Delahousse J; Pedinielli JL
    Encephale; 1986; 12(4):169-74. PubMed ID: 2878801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroleptic discontinuation syndromes.
    Tranter R; Healy D
    J Psychopharmacol; 1998; 12(4):401-6. PubMed ID: 10065916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical predictors of relapse following neuroleptic withdrawal.
    Buchanan RW; Kirkpatrick B; Summerfelt A; Hanlon TE; Levine J; Carpenter WT
    Biol Psychiatry; 1992 Jul; 32(1):72-8. PubMed ID: 1356490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute psychosis precipitated by withdrawal of anticonvulsant medication.
    Demers-Desrosiers LA; Nestoros JN; Vaillancourt P
    Am J Psychiatry; 1978 Aug; 135(8):981-2. PubMed ID: 665849
    [No Abstract]   [Full Text] [Related]  

  • 35. Supersensitivity psychosis in patients with schizophrenia after sudden olanzapine withdrawal.
    Llorca PM; Vaiva G; Lancon C
    Can J Psychiatry; 2001 Feb; 46(1):87-8. PubMed ID: 11221497
    [No Abstract]   [Full Text] [Related]  

  • 36. More data on supersensitivity psychosis.
    Witschy JK; Malone GL; Holden LD
    Am J Psychiatry; 1984 Oct; 141(10):1302. PubMed ID: 6148896
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of neuroleptic withdrawal on plasma prolactin: a possible marker of receptor adaptation.
    Kirkpatrick B; Buchanan RW; Maeda K; Carpenter WT; Jauch D; Tamminga CA
    Biol Psychiatry; 1989 Jun; 26(2):131-8. PubMed ID: 2567610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tardive dyskinesia: side effect or not?
    Curran JP
    Am J Psychiatry; 1973 Apr; 130(4):406-10. PubMed ID: 4144163
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.
    Mayoral-van Son J; de la Foz VO; Martinez-Garcia O; Moreno T; Parrilla-Escobar M; Valdizan EM; Crespo-Facorro B
    J Clin Psychiatry; 2016 Apr; 77(4):492-500. PubMed ID: 26759992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe exacerbation of psychosis after sudden withdrawal of chlorpromazine in the treatment of methamphetamine-associated psychosis with aripiprazole and chlorpromazine: 2 case reports.
    Wang G; Devi Thakoor JP; Wang X; Hao W
    J Addict Med; 2014; 8(6):479-81. PubMed ID: 25303986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.